TTechnology Read More Breakthrough Parkinson’s Drug Targets Disease at Its Genetic RootsMay 21, 2026 Scientists have reported promising early results from a novel Parkinson’s treatment designed to suppress the activity of a…
HHealth Read More New mouse model reveals primary trigger of rare muscle disorderApril 24, 2026 Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and…
HHealth Read More New gene therapy improves hearing in patients with rare genetic deafnessApril 23, 2026 A new international study co-led by investigators from Mass General Brigham and the Eye & ENT Hospital of…
HHealth Read More Multicentre gene therapy for OTOF-related deafness followed up to 2.5 yearsApril 22, 2026 Yasunaga, S. et al. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form…
HHealth Read More ‘Deafness reversed’: Scientists restore hearing in 10 patients with a single-injection gene therapy breakthrough |April 5, 2026 A clinical study has delivered one of the clearest signs yet that gene therapy can restore hearing in…
HHealth Read More The Medicine Maker | mRNA Expands into Fertility MedicineMarch 27, 2026 Credit: Mito Kanatsu-Shinohara Researchers in Japan have demonstrated that messenger RNA (mRNA) therapy…
HHealth Read More Gene-modified pancreas cells offer hope for people with type 1 diabetesMarch 4, 2026 Key Insights A proof-of-concept trial in a single patient has shown that genetically engineered pancreas cells can…
HHealth Read More Genetic mismatch identified as major risk factor in cord blood transplantationFebruary 21, 2026 A Japanese study of more than 7,400 patients has identified a genetic mismatch that sharply increases the risk…
SScience Read More Eyes of the world’s longest-living vertebrate, the Greenland shark, show little ageingJanuary 10, 2026 Swimming at a crawl with cloudy eyes and mottled skin, the Greenland shark looks like it’s seen better…
HHealthcare Read More AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)January 9, 2026 Durham, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated…
HHealthcare Read More 7 medical breakthroughs of 2025January 3, 2026 For most diseases, the challenge is not a lack of effort but the limits of existing tools and…
HHealth Read More Science in 2026: what to expect this year – NatureJanuary 1, 2026 Science in 2026: what to expect this year NatureDrugs to Watch in 2026 Dermatology TimesScience in 2026: Breakthroughs Set to…